Protein and DNA analysis for the prenatal diagnosis of alpha 2-laminin-deficient congenital muscular dystrophy

Protein and DNA analysis for the prenatal diagnosis of alpha 2-laminin-deficient congenital muscular dystrophy

Author Yamamoto, L. U. Google Scholar
Gollop, T. R. Google Scholar
Naccache, N. F. Google Scholar
Pavanello, RCM Google Scholar
Zanoteli, E. Google Scholar
Zatz, M. Google Scholar
Vainzof, M. Google Scholar
Institution Universidade de São Paulo (USP)
Inst Med Fetal & Genet Humana
Universidade Federal de São Paulo (UNIFESP)
Abstract Congenital muscular dystrophies (CMD) are characterized by neonatal hypotonia and/or artrogriposis associated with a dystrophic muscle biopsy. the CMD1A form is caused by a deficiency of the alpha2 chain of laminin 2 (LAMA2 gene at 6q2), a protein present in the basal lamina of muscle fibers, in Schwann cells, epidermis, and in fetal trophoblastic tissue. This allows its Study for prenatal diagnosis in the chorionic villous (CV), which was performed in a family with one deceased affected CMD1A child. Immunohistochemical analysis of the CV using antibodies against the C- and N-terminal domains of the alpha2-laminin protein showed a normal positive labeling for both antibodies in the at-risk CV, which did not differ from the normal control CV. the integrity of the CV membrane was confirmed through the analysis with antibodies against alpha1, beta1, and gamma1 laminins. DNA study using markers flanking the 6q2 region showed that the affected patient and the at-risk fetus did not share the same haplotype. Therefore, the fetus was considered normal through both methodologies, which was confirmed after the birth of a clinically normal male baby. As the LAMA2 gene is very large and the spectrum of mutations causing disease is wide, the analysis of the protein in muscle biopsy has been largely used for the diagnosis. Besides, the possibility to detect it in the chorionic villous, mainly using positive markers, also offers a powerful tool for prenatal diagnosis.
Keywords alpha 2-laminin
congenital muscular dystrophy
prenatal diagnosis
Language English
Date 2004-09-01
Published in Diagnostic Molecular Pathology. Philadelphia: Lippincott Williams & Wilkins, v. 13, n. 3, p. 167-171, 2004.
ISSN 1052-9551 (Sherpa/Romeo, impact factor)
Publisher Lippincott Williams & Wilkins
Extent 167-171
Access rights Closed access
Type Article
Web of Science ID WOS:000223575800007

Show full item record


File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)




My Account